Literature DB >> 9812071

Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction.

I Reindl1, K D Wernecke, C Opitz, R Wensel, D König, T Dengler, I Schimke, F X Kleber.   

Abstract

BACKGROUND: Patients with chronic heart failure show impairment of ventilatory efficiency, defined as the relation between ventilation and carbon dioxide output. It is caused by ventilation of excess physiologic dead space. We hypothesized a role of active vasoconstriction in the increase of physiologic dead space, presumed to lead to alveolar hypoperfusion. METHODS AND
RESULTS: In 57 patients with chronic heart failure (New York Heart Association classification II through IV, ejection fraction 25.6%+/-10.4%) and 7 control subjects, gas exchange at rest and on exercise was compared with hemodynamic measurements and, in a subgroup of 15 patients, with endothelin-1, epinephrine, and norepinephrine levels in the pulmonary and systemic circulation. Ventilatory efficiency at rest (VE/VCO2 ratio) correlated with ventilatory efficiency on exercise (VE vs VCO2 slope). Impairment of ventilatory efficiency correlated strongly negative with exercise tolerance (maximal oxygen uptake: r = -0.67) and cardiac output (r = -0.66) and positive with pulmonary hypertension (mean pulmonary artery pressure: r = 0.69, pulmonary vascular resistance: r = 0.60). None of the vasoconstrictors correlated with reduction of ventilatory efficiency in the subgroup studied.
CONCLUSIONS: Impairment of ventilatory efficiency in chronic heart failure is correlated with resting pulmonary artery pressures and associated with the impairment of exercise capacity. An imbalance of pulmonary vascular tone probably leads to both pulmonary hypertension and alveolar hypoperfusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9812071     DOI: 10.1016/s0002-8703(98)70121-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  28 in total

1.  An examination of exercise mode on ventilatory patterns during incremental exercise.

Authors:  Adrian D Elliott; Fergal Grace
Journal:  Eur J Appl Physiol       Date:  2010-06-17       Impact factor: 3.078

Review 2.  Pulmonary hypertension with left-sided heart disease.

Authors:  Marco Guazzi; Ross Arena
Journal:  Nat Rev Cardiol       Date:  2010-10-05       Impact factor: 32.419

Review 3.  The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review.

Authors:  Ross Arena; Jonathan Myers; Marco Guazzi
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

Review 4.  Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 5.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

6.  Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification.

Authors:  L C Davies; D P Francis; M Piepoli; A C Scott; P Ponikowski; A J Coats
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

7.  Wave intensity as a useful modality for assessing ventilation-perfusion imbalance in subclinical patients with hypertension.

Authors:  Yoshie Nogami; Yoshihiro Seo; Masayoshi Yamamoto; Tomoko Ishizu; Kazutaka Aonuma
Journal:  Heart Vessels       Date:  2018-02-12       Impact factor: 2.037

8.  The oxygen uptake efficiency slope is reduced in older patients with heart failure and a normal ejection fraction.

Authors:  Ross Arena; Peter Brubaker; Brian Moore; Dalane Kitzman
Journal:  Int J Cardiol       Date:  2009-01-26       Impact factor: 4.164

9.  Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.

Authors:  Akifumi Higashi; Yoshihiro Dohi; Sayuri Yamabe; Hiroki Kinoshita; Yoshiharu Sada; Toshiro Kitagawa; Takayuki Hidaka; Satoshi Kurisu; Hideya Yamamoto; Yuji Yasunobu; Yasuki Kihara
Journal:  Heart Vessels       Date:  2017-05-30       Impact factor: 2.037

10.  Prognostic value of brain natriuretic peptide and enhanced ventilatory response to exercise in patients with chronic heart failure.

Authors:  Angela Beatrice Scardovi; Renata De Maria; Andrea Celestini; Claudio Coletta; Nadia Aspromonte; Silvia Perna; Marina Parolini; Roberto Ricci
Journal:  Intern Emerg Med       Date:  2008-06-17       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.